Challenge–dechallenge–rechallenge

Results: 14



#Item
1ADVERSE EVENT (AE) REPORT FORM UID number (for office use only): ___________________ Date of report: ___________ Type of report: ☐ Initial ☐ follow up/number (Please specify) __________ Reporter Details: Reporter is

ADVERSE EVENT (AE) REPORT FORM UID number (for office use only): ___________________ Date of report: ___________ Type of report: ☐ Initial ☐ follow up/number (Please specify) __________ Reporter Details: Reporter is

Add to Reading List

Source URL: 202.154.165.176

Language: English - Date: 2014-04-16 05:26:13
2On Evidence, Medical and Legal

On Evidence, Medical and Legal

Add to Reading List

Source URL: www.donaldmiller.com

Language: English - Date: 2006-05-24 21:51:13
3U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
4U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
5Microsoft PowerPoint - V Seligman summary.ppt

Microsoft PowerPoint - V Seligman summary.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English
6U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
7M & V   Causality Assessment Scale   I. Temporal Relationship Between Drug Intake and the Onset of Clinical Picture  A. Time from drug intake until the onset of the first clinical or labo

M & V   Causality Assessment Scale   I. Temporal Relationship Between Drug Intake and the Onset of Clinical Picture  A. Time from drug intake until the onset of the first clinical or labo

Add to Reading List

Source URL: www.livertox.nih.gov

Language: English - Date: 2013-11-05 10:07:24
8U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
9Epiduo Gel: Safety Review

Epiduo Gel: Safety Review

Add to Reading List

Source URL: www.fda.gov

Language: English
10Positive Rechallenge Cases of AccutaneB-Associated Depressive Symptoms Marilyn R. Pitts, Pharm.D. Safety Evaluator Food and Drug Administration

Positive Rechallenge Cases of AccutaneB-Associated Depressive Symptoms Marilyn R. Pitts, Pharm.D. Safety Evaluator Food and Drug Administration

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2000-09-27 10:24:19